Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘directed’

« Older Entries

Brad Cole: Genomic Science and Patient-Directed Cancer Treatment Decisions – 2012 T3 Talks

By on Thursday, March 28th, 2013 | No Comments

Full Title: Empowering Patient-Directed Cancer Treatment Decisions through Genomic-Based Clinical Laboratory Services T3 Talks at Biola University: Intellige…

Read More...

Team finds gene that promotes drug resistance in cancer

By on Wednesday, January 16th, 2013 | No Comments

Scientists from the University of Iowa and Brigham Young University have identified a gene that may be a target for overcoming drug resistance in cancer. The finding could not only improve prognostic and diagnostic tools for evaluating cancer and monitoring patients’ response to treatment but also could lead to new therapies directed at eradicating drug-resistant cancer cells. The University of Iowa is home to the Holden Comprehensive Cancer Center.

Read More...

Vanderbilt’s Dr. Mia Levy presents: Informatics to Support Genome Directed Cancer Treatment

By on Tuesday, January 15th, 2013 | No Comments

Dr. Mia Levy of Vanderbilt University presents: Informatics to Support Genome-directed Cancer Medicine.

Read More...

Tom Everhart: Finding love through cancer & Snoopy

By on Friday, January 11th, 2013 | No Comments

Tom Everhart is a world-renown fine artist educated by Charles Schulz, creator of Peanuts. Tom has survived Stage 4 colon & liver cancer for 23 years. He shares his story with YouInspire about finding love through his hardships and how Snoopy changed his life. Produced by: YouInspire Inc – www.youinspire.org Directed by Kyle Milardo Shot By: Sean Emer Edited by: James Witker Scored by: Brett Long Assisted by: Mike Sweeney Special thanks to Tom Everhart Studio (www.everhartstudio.com)

Read More...

Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

By on Thursday, May 10th, 2012 | No Comments

Condition :   Liver Cancer Interventions :   Procedure: Standard fluid management;   Device: Goal directed fluid therapy with the FloTrac sensor Sponsors :   Memorial Sloan-Kettering Cancer Center;   Memorial Sloan-Kettering Cancer Center Recruiting – verified May 2012

Read More...

Target set on cancer gene MCL1

By on Saturday, April 21st, 2012 | No Comments

A research team pursuing one of the most commonly altered genes in cancer has laid a critical foundation for understanding this gene that could point the way toward developing drugs against it. The new research pinpoints compounds that repress MCL1′s activity and highlights an important companion gene that predicts if a tumor is dependent upon MCL1 for survival. Together, these tools suggest a path toward new therapeutics directed at MCL1.

Read More...

Cancer Vaccines And The Challenges They Present

By on Thursday, March 8th, 2012 | No Comments

The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical trials, according to a review published in the Journal of the National Cancer Institute…

Read More...

Breast cancer foes in Northeast Ohio announce a different approach toward a cure

By on Saturday, October 22nd, 2011 | No Comments

… may be surprised to know that in 2011, someone in our country dies of breast cancer every 14 minutes. With all the attention and resources directed to breast cancer, the …

Read More...

Ready, set, mo, get on board for Movember

By on Friday, October 21st, 2011 | No Comments

… of Movember which aims to raise vital funds and awareness for mens health, specifically prostate cancer and depression in men. The funds raised are directed to programs run directly by …

Read More...

Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia

By on Monday, October 17th, 2011 | No Comments

Condition :   Acute Myeloid Leukemia Intervention :   Other: Risk-adapted, MRD-directed therapy Sponsor :   Gruppo Italiano Malattie EMatologiche dell’Adulto Not yet recruiting – verified October 2011

Read More...
« Older Entries